Drug
Seltorexant
Seltorexant: highest development phase Phase 3, developed by Johnson & Johnson. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Johnson & Johnson
Trials
| Drug | Phase | Indication |
|---|---|---|
| Seltorexant NCT04513912 | Phase 3 | Depressive Disorder, Major |
Latest
No recent events.
Follow Seltorexant on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.